Suven Life Sciences Ltd Quarterly Results

Gross Sales

1.47

1.61

2.57

1.01

2.39

Excise Duty

0

0

0

0

0

Net Sales

1.47

1.61

2.57

1.01

2.39

Other Operating Income

0

0

0

0

0

Other Income

1.22

1.63

4.04

4.01

4.28

Total Income

2.69

3.24

6.61

5.01

6.67

Total Expenditure

45.29

40.82

54.78

31.54

32.67

PBIDT

-42.6

-37.58

-48.17

-26.53

-26

Interest

0

0.01

0.02

0.02

0.03

PBDT

-42.6

-37.58

-48.19

-26.55

-26.03

Depreciation

1.35

1.53

1.46

1.49

1.51

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

-1

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-43.94

-39.12

-49.64

-28.04

-26.54

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-43.94

-39.12

-49.64

-28.04

-26.54

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-43.94

-39.12

-49.64

-28.04

-26.54

EPS (Unit Curr.)

-2.02

-1.79

-2.27

-1.29

-1.22

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

21.81

21.81

21.81

21.81

21.81

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-2,897.95

-2,334.16

-1,874.31

-2,626.73

-1,087.86

PBDTM(%)

-2,897.95

-2,334.16

-1,875.09

-2,628.71

-1,089.12

PATM(%)

-2,989.11

-2,429.81

-1,931.51

-2,776.23

-1,110.46